Evaluation of Lung Nodules/Masses
Lung cancer is the second most common cause of cancer in the United States for both men and women, and the most common cause of cancer-related death. The relatively asymptomatic nature of lung cancer can lead to higher incidence of advanced disease at time of diagnosis, with a typically worse prognosis. As a result, the 5-year survival rate for lung cancer patients in general is only 15%, whereas survival for patients diagnosed with early-stage disease who undergo surgical resection is 85%. Accordingly, the US Preventive Services Task Force recommends low-dose CT scanning of the chest as a screening tool for those individuals at risk for developing lung cancer.
The Texas IPS Lung Nodule/Lung Cancer Clinic provides both lung cancer screening and direct pathways for diagnosis and treatment when necessary. We are firmly committed to the process of early detection and treatment of potential lung cancers for the members of our community.
OUR METHODS OF HEALING
- Cardiac surgery critical care
- Critical care management
- Interstitial lung disease
- Obstructive lung disease
- Sleep disorders
- Pulmonary rehabilitation
- Interventional pulmonary service
- Pulmonary embolism
- Hospital discharge & post ICU outpatient clinic
- Quality improvement
- COVID-19 recovery
- Neuro critical care
- Evaluation of lung nodules/masses
- Pulmonary hypertension
- Smoking cessation program
- Home and facility sleep testing
Lung cancer claims more lives in America every year than any other form of cancer. In 2020, 136,084 people died of lung cancer. That’s more than double the next-deadliest cancer—51,869 people died of colorectal cancer the same year.
Dr. Ali Abedi and his team here at Texas IPS were interviewed by SA Live on KSAT 12 on learning how to take a lung cancer risk assessment test. Lung cancer is one of the most common cancers and leading killers in both men and women in the United States.